Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-06-02
DOI
10.3389/fnagi.2015.00104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor
- (2014) Elena Lonati et al. Frontiers in Cellular Neuroscience
- Green tea catechin leads to global improvement among Alzheimer's disease-related phenotypes in NSE/hAPP-C105 Tg mice
- (2013) Hwa Ja Lim et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats
- (2013) Nagaraja Haleagrahara et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
- (2012) Chuang Guo et al. NEUROBIOLOGY OF AGING
- Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
- (2012) Chuang Guo et al. NEUROCHEMISTRY INTERNATIONAL
- Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice
- (2012) J. M. Fine et al. EXPERIMENTAL BRAIN RESEARCH
- Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
- (2010) Y. Avramovich-Tirosh et al. Current Alzheimer Research
- Novel drug targets based on metallobiology of Alzheimer's disease
- (2010) Sanghamitra Bandyopadhyay et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide
- (2009) David Schubert et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
- (2009) Jae Woong Lee et al. JOURNAL OF NUTRITION
- Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke
- (2009) L. R. Hanson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The application of proteomics for studying the neurorescue activity of the polyphenol (−)-epigallocatechin-3-gallate
- (2008) Orly Weinreb et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Role of HIF-1 and NF-κB Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals
- (2008) Lorenza Tacchini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Environmental-induced oxidative stress in neurodegenerative disorders and aging
- (2008) Lucia Migliore et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Reversion of age-related recognition memory impairment by iron chelation in rats
- (2007) Maria Noêmia Martins de Lima et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More